Prediction of animal clearance using naïve Bayesian classification and extended connectivity fingerprints.
In silico models were developed for predicting high animal clearance using naïve Bayesian classification and extended connectivity fingerprints. Validation and test sets were created from a structurally diverse database of mouse, rat, dog, and monkey clearance (CL) representing approximately 20,000 unique compounds. Model performance was compared with experimental predictors used widely in drug discovery, namely in vitro intrinsic clearance (CL(i)) and CL from a lower preclinical species. The Bayesian model for dog CL was a better predictor than experimental rat or mouse CL. The Bayesian model for rat CL performed at least as well as mouse CL. Bayesian models outperformed mouse, rat, and monkey CL(i) for predicting mouse, rat, and monkey CL, respectively. These models can be used to optimize chemical libraries, direct new chemical synthesis and increase efficiency of screening cascades for lead optimization while reducing overall drug discovery cost, time and animal usage.
McIntyre
T A
TA
GlaxoSmithKline, Drug Metabolism and Pharmacokinetics, Collegeville, PA 19426, USA.
Han
C
C
Davis
C B
CB
D000818:Animals; D001499:Bayes Theorem; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D051379:Mice; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism*; D010599:Pharmacokinetics; D051381:Rats
D004364:Pharmaceutical Preparations